Lipotec, winner of the Silver Green Ingredient Award 2019

Apr 12, 2019 | Projects

Lipotec, winner of the Silver Green Ingredient Award 2019

Our client Lipotec Active Ingredients has won the Silver Green Ingredient Award during In-Cosmetics Global this year with his innovative LUMICEASE blue ingredient. This award organised in partnership with Ecovia Intelligence is given to an ingredient that makes a significant environmental or social difference in the area of sustainability.[/vc_column_text][us_separator][vc_video link=”https://vimeo.com/330063989/bbeb34adf5″ align=”center”][us_separator][vc_column_text]This award recognizes the fact that Lipotec Active Ingredients colaborates with the local NGO Paisatges Vius as part of their commitment with the environment by sponsoring a project dedicated to the conservation of the aquatic environment and endangered species of the Pyrenean.

LUMICEASE blue ingredient is addressed to prepare, protect and repair the skin from solar and artificial blue light-induced damage by activating opsins on the skin and promotes adaptive responses, helping prepare the skin for future exposure and minimize the main signs of both digital and solar agin.

ARE YOU INTERESTED IN SCIENTIFIC ANIMATION AND COMMUNICATION?

Related news

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio

High performance sustainable material: Sappi Symbio Sappi is a global company focused on providing dissolving pulp, paper pulp, paper-based and biorefinery solutions to its customers in over 150 countries. They invest in research and development programs, unlocking...

cPass™ technology by GenScript

cPass™ technology by GenScript

cPass™ Technology by GenScript Coronaviruses are a large family of viruses that may cause illness in animals or humans.  In humans, several coronaviruses are known to cause respiratory infections ranging from the common cold to more severe diseases such as Middle East...

B2B device: from breast to bone

B2B device: from breast to bone

B2B Device: From Breast To Bone ABOUT CLIENT: B2B is an EU-funded project that aims to develop a breakthrough technology that for the first time dissects the steps of spontaneous breast cancer metastasis to the bone and captures the 3D complexity of the process. The...